Reliability and convergent validity of two outcome instruments for pemphigus. - Wikidata - wikimedia - TriplyDB

Reliability and convergent validity of two outcome instruments for pemphigus.

Reliability and convergent validity of two outcome instruments for pemphigus.

http://www.wikidata.org/entity/Q34441185

about

Severity score indexes for blistering diseases Scoring systems in pemphigus Management of pemphigus vulgaris: challenges and solutions Molecular diagnosis in autoimmune skin blistering conditions Jean-Claude Bystryn 1938-2010. An obituary.The Epidermolysis Bullosa Disease Activity and Scarring Index (EBDASI): grading disease severity and assessing responsiveness to clinical change in epidermolysis bullosa.Autoimmune blistering diseases in females: a review.Definitions and outcome measures for bullous pemphigoid: recommendations by an international panel of experts.A multicentre randomized trial of the treatment of patients with pemphigus vulgaris with infliximab and prednisone compared with prednisone alone.A pilot comparison study of four clinician-rated atopic dermatitis severity scales.Validation of the Mayo Hip Score: construct validity, reliability and responsiveness to change.Reliability of the autoimmune bullous disease quality of life (ABQOL) questionnaire in the USA Rituximab for autoimmune blistering diseases: recent studies, new insights.Reliability and convergent validity of the cutaneous sarcoidosis activity and morphology instrument for assessing cutaneous sarcoidosis.Quality of life in patients with bullous dermatoses.Diagnosis and treatment of pemphigus.Outcome measures for autoimmune blistering diseases.Pemphigus vulgaris: an evidence-based treatment update.Validation studies of outcome measures in pemphigus.The reliability of the Cutaneous Dermatomyositis Disease Area and Severity Index (CDASI) among dermatologists, rheumatologists and neurologists.Measurement of disease severity in cutaneous autoimmune diseases.There might be a role for CD200 in the pathogenesis of autoimmune and inflammatory skin disorders.Herpes simplex virus reactivation as a trigger of mucous lesions in pemphigus vulgaris.The impact of stratifying initial dose of corticosteroids by severity of pemphigus vulgaris on long-term disease severity.Burden of disease during quiescent periods in patients with pemphigus.Quantifying disease extent in pemphigus.Miniaturization of sebaceous glands: A novel histopathological finding in pemphigus vulgaris and pemphigus foliaceus of the scalp.British Association of Dermatologists' guidelines for the management of pemphigus vulgaris 2017.Study of oral, ear, nose and throat involvement in pemphigus vulgaris by endoscopic examination.A prospective study on clinical response and cell-mediated immunity of pemphigus patients treated with rituximab.S2k guideline for the diagnosis of pemphigus vulgaris/foliaceus and bullous pemphigoid.Evaluation of pharyngo-oesophageal involvement in pemphigus vulgaris and its correlation with disease activity.Evaluating the Efficacy of Double-Filtration Plasmapheresis in Treating Five Patients With Drug-Resistant Pemphigus.IVIG therapy in pemphigus vulgaris has corticosteroid-sparing and immunomodulatory effects.Yearly reduction of glucocorticoid dose by 50% as tapering schedule achieves complete remission for 124 pemphigus vulgaris patients.Rituximab treatment in pemphigus vulgaris: effect on circulating Tregs.Calculation of cut-off values based on the Autoimmune Bullous Skin Disorder Intensity Score (ABSIS) and Pemphigus Disease Area Index (PDAI) pemphigus scoring systems for defining moderate, significant and extensive types of pemphigus.Emerging treatment options for the management of pemphigus vulgaris.Pemphigus

P2860

Q24604349-43548A65-F474-4D47-A359-5DE34E67F4A4 Q24624530-D21C5893-1E7B-460E-83E6-26F3C03DBD2D Q26778895-5750C256-3370-44F4-AEEE-5C2DF91CEB72 Q27025483-5E0CCF69-1199-411F-8332-9069A2A04844 Q30399726-3900478C-6E60-415B-817D-E43D528D9872 Q33626137-5F44F48B-661E-413E-B9ED-17A250A99A8D Q33640302-EB73161B-FC1F-44EA-B7F0-61B20A41AEBC Q34067962-B1E0BA0E-B8DB-47FD-B747-66B8B96E7FD6 Q35079629-A380BC23-0F32-4F96-9427-6057B73A7937 Q35609349-3A12BDB7-4FF5-4108-AD66-85D77CE994D7 Q35898113-E7DE1348-F579-4BE6-84D1-71EA85B44863 Q36619255-67FBF125-CC2F-49B5-9D54-63B31FC925B3 Q36751954-3870CA0A-2A7B-451A-AC84-EE116B908327 Q37404210-36D38AA8-634D-401C-B441-C9BEE4B95AFA Q37444029-97929004-5F49-491D-B377-E29A6E411900 Q38031283-B28E0755-8B17-4520-8DE1-3B22828EE716 Q38307352-B3AC2E8E-D68B-4543-99FF-8C9025B36E32 Q38345404-2CE5F85D-ABB1-467B-86B3-EA756E318BC8 Q38793267-0F6C4792-A3FA-4051-87DE-27C68B3C013C Q39076011-75A93FC6-08DA-4F6E-8F17-E79C3BAE47E2 Q41558860-0654D4CA-893F-4B12-A3AF-F2D521A48C35 Q41822047-5EE43ACC-28C2-4C2E-98ED-50F8C39C33D3 Q42222595-311B3B4A-AB5A-406D-9225-8C7724C1E979 Q45924533-89E40FD9-8C55-4332-8DC5-1AA626A67919 Q48096667-BC1AFEEB-E39E-4BE3-B27C-15E6BE02CE97 Q48131073-A6712477-73A9-43C8-81F5-3A9776DC798F Q48249953-42F37094-2C4C-410D-8EEC-33F4701ED5E3 Q49382688-BC412D3E-40C9-45DF-9989-01C7B7B1D564 Q50935201-CC8AACA7-018C-427D-8D1F-600B62D62601 Q51065320-FF34A39F-8987-4A06-BF1F-08F7087D2AAA Q52865044-4AF80ABA-A64E-48E8-9F6C-B555979685B1 Q53103350-42191FB5-4634-478A-BF39-2E5E9FA0FAC7 Q53189486-9876906B-0099-4B4A-A3D5-91268C593A8F Q53655469-3F7BFC3A-04F1-4EAA-BE0E-30FDF523808F Q53674476-8138CD9E-3348-4E51-86D5-505EDAB700EB Q53727241-8385C530-8222-4C66-BFAE-5192F0C6D69E Q53816009-B750B3A9-07AE-4EC8-A9E0-9E8EB3DABCF2 Q55433740-06B6DC55-C3DD-40B1-81CA-4AC10762401C Q56603745-86BB3CDF-16FB-4B3C-91E2-B5FBB8C89BFC

P2860

Reliability and convergent validity of two outcome instruments for pemphigus.

http://www.wikidata.org/entity/Q34441185

description

2009 nî lūn-bûn

@nan

2009 թուականի Ապրիլին հրատարակուած գիտական յօդուած

@hyw

2009 թվականի ապրիլին հրատարակված գիտական հոդված

@hy

2009年の論文

@ja

2009年論文

@yue

2009年論文

@zh-hant

2009年論文

@zh-hk

2009年論文

@zh-mo

2009年論文

@zh-tw

2009年论文

@wuu

name

Reliability and convergent validity of two outcome instruments for pemphigus.

@ast

Reliability and convergent validity of two outcome instruments for pemphigus.

@en

Reliability and convergent validity of two outcome instruments for pemphigus.

@nl

type

label

Reliability and convergent validity of two outcome instruments for pemphigus.

@ast

Reliability and convergent validity of two outcome instruments for pemphigus.

@en

Reliability and convergent validity of two outcome instruments for pemphigus.

@nl

prefLabel

Reliability and convergent validity of two outcome instruments for pemphigus.

@ast

Reliability and convergent validity of two outcome instruments for pemphigus.

@en

Reliability and convergent validity of two outcome instruments for pemphigus.

@nl

P1433

Q34441185-7750409F-3734-4A20-93D7-FC277585D5B0

P1476

Q34441185-3099916E-2F03-4510-8452-6B901FAF470F

P2093

Q34441185-028A725F-E4BB-4660-ABAD-590B828D8194

Q34441185-0AA5E304-410D-4888-89A0-E3B6B05265ED

Q34441185-313CF4FB-143F-45AC-8914-82D130FDBF2E

Q34441185-3B23922C-C76F-4543-9934-493C249DE84F

Q34441185-65CC14D3-4B68-4069-855C-F960629B1DCB

Q34441185-6B14B816-94C5-48BA-94B6-9261E4CD43A1

Q34441185-84122EA9-A04C-4FFF-90B4-CAD188DE5AD4

Q34441185-9ECEA536-093F-41BB-8B45-59A07D3869FF

Q34441185-A2BF8A1A-F832-4EC0-AE3C-9380248BD224

Q34441185-A352C960-71C9-496A-A5AE-C880224A14D9

P2860

Q34441185-003F7C29-222C-4328-92AE-B587DB57A7A7

Q34441185-1110C538-8AB6-473C-A13E-A106999FE077

Q34441185-59ACB93F-780B-4FD6-8C10-872EDD36A802

Q34441185-64651110-0BFA-44B3-9B61-83B71B17B3E7

Q34441185-6534661C-8200-4A5A-8D14-CE60246FF06C

Q34441185-90A3B74C-9C9B-47AA-A228-E53F90852FA3

Q34441185-EF4C6BFD-83AA-4E07-8D18-36DD796A0025

Q34441185-F0552C7F-3A6C-4956-BE13-9734BF23E2C5

P2888

Q34441185-1F35A521-8DB7-4A4E-A764-9319C81989C6

P304

Q34441185-25A6E980-7E86-460B-A8B5-8A7191741C58

P31

Q34441185-9991D0D4-B484-4452-8435-719F7D2982C9

P356

Q34441185-FEEEEFC5-A748-4C63-976A-81D57EC407B5

P407

Q34441185-388FAE3C-33FD-4FF8-B417-3DBA0F902783

P433

Q34441185-0302FF5D-F5E8-448D-A7B9-1571F10C1CBB

P478

Q34441185-AC98D1AF-D105-4CBE-8906-047430E51EE7

P50

Q34441185-4F68C00E-61B3-4190-8335-42210DBBF781

P577

Q34441185-245C902D-2D10-4657-BB2C-3445C18A4175

P5875

Q34441185-CC65B01E-AB8E-4B86-869E-E783A710389C

P6179

Q34441185-A6A0AC69-16CB-46FE-B0FC-B8CF23184B4E

P698

Q34441185-E398B12E-1915-4DB3-B51F-00912794808C

P932

Q34441185-DA07D04D-C8A9-4118-9591-B9081A26740D

P356

P1433

Journal of Investigative Dermatology

P1476

Reliability and convergent validity of two outcome instruments for pemphigus.

@en

P2093

Aimee S Payne

http://www.w3.org/2001/XMLSchema#string

Amit G Pandya

http://www.w3.org/2001/XMLSchema#string

Benjamin B Werth

http://www.w3.org/2001/XMLSchema#string

Carmela Vittorio

http://www.w3.org/2001/XMLSchema#string

David Rubenstein

http://www.w3.org/2001/XMLSchema#string

David Woodley

http://www.w3.org/2001/XMLSchema#string

Dedee F Murrell

http://www.w3.org/2001/XMLSchema#string

Erik A Williams

http://www.w3.org/2001/XMLSchema#string

Jean-Claude Bystryn

http://www.w3.org/2001/XMLSchema#string

Joyce Okawa

http://www.w3.org/2001/XMLSchema#string

P2860

The Measurement of Observer Agreement for Categorical Data

Intraclass correlations: uses in assessing rater reliability

Consensus statement on definitions of disease, end points, and therapeutic response for pemphigus.

Outcome measures of disease severity in atopic eczema.

Introducing a novel Autoimmune Bullous Skin Disorder Intensity Score (ABSIS) in pemphigus.

A review of two controlled multicenter trials comparing 0.05% halobetasol propionate ointment to its vehicle in the treatment of chronic eczematous dermatoses.

Topical bexarotene therapy for patients with refractory or persistent early-stage cutaneous T-cell lymphoma: results of the phase III clinical trial.

Cutaneous symptoms of dermatomyositis significantly impact patients' quality of life.

P2888

P304

2404-2410

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1038/JID.2009.72

http://www.w3.org/2001/XMLSchema#string

P407

P433

10

http://www.w3.org/2001/XMLSchema#string

P478

129

http://www.w3.org/2001/XMLSchema#string

P50

Andrea B Troxel

P577

2009-04-09T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

24267815

http://www.w3.org/2001/XMLSchema#string

P6179

1018774058

http://www.w3.org/2001/XMLSchema#string

P698

19357707

http://www.w3.org/2001/XMLSchema#string

P932

3010359

http://www.w3.org/2001/XMLSchema#string